Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Mov Disord. 2020 Nov 2;36(3):642–650. doi: 10.1002/mds.28360

TABLE 1.

Demographic and clinical characteristics of included patients with PD

PD
Age 67.8 (7.6)
Gender, male:female 67:19
Education, y 15.6 (2.7)
Motor disease duration, y 5.8 (4.6)
Hoehn and Yahr 2.4 (0.6)
MDS-UPDRS Part III 34.3 (12.1)
LED, mg 647.2 (410)
PD-MCI, n (%) 39 (45.3%)
MoCA 26.2 (3.0)
z score memory −0.44 (1.03)
z score attention −0.41 (0.87)
z score executive function −0.55 (1.27)
z score language −0.48 (1.11)
z score visuospatial function −0.12 (0.84)

Means (standard deviations) are presented for numerical variables. Abbreviations: MDS-UPDRS, Movement Disorder Society–Unified Parkinson’s Disease Rating Scale; LED, levodopa equivalent dose; PD-MCI, Parkinson’s Disease Mild Cognitive Impairment; MoCA, Montreal Cognitive Assessment.